Recent Topic of Saturated Fatty Acid (SFA) for Atherosclerotic Diseases

Masahiro Bando^1*, Hiroshi Bando^2
1Department of Gastroenterology and Oncology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
²Medical Research / Tokushima University, Tokushima, Japan

Corresponding Author: Masahiro BANDO, RD, PhD
Address: Tokushima University, Kuramoto 3-18-15, Tokushima 770-8503, Japan.
Received date: 06 January 2021; Accepted date: 08 February 2021; Published date: 15 February 2021

Citation: Bando M, Bando H. Recent Topic of Saturated Fatty Acid (SFA) for Atherosclerotic Diseases. J Health Care and Research. 2021 Feb 15;2(1):13-16.

Copyright © 2021 Bando M, Bando H. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: Saturated Fatty Acid (SFA), Atherosclerotic Cardiovascular Disease (ASCVD), Prospective Urban Rural Epidemiology (PURE), Monounsaturated Fatty Acid (MUFA), Low Carbohydrate Diet (LCD)

Abstract

Whether saturated fatty acid (SFA) has a clinical influence on atherosclerotic cardiovascular disease (ASCVD) or not has been disputed. Prospective Urban Rural Epidemiology (PURE) study was recently summarized from 21 countries with about 150 thousand data. Dairy intake was negatively correlated with the prevalence of metabolic syndrome and the incidence of diabetes and hypertension. To increase the intake of dairy products would be easy and inexpensive to continue for treatment. Polyunsaturated fatty acid (PUFA) and monounsaturated fatty acid (MUFA) may reduce atherosclerotic diseases with beneficial effects. Clinical evidence of SFA will be hopefully accumulated for practice and research in the future.